Phase 1CompletedINTERVENTIONAL
A Study of LY3305677 in Participants With Type 2 Diabetes
ClinicalTrials.gov · NCT03928379 · Registry updated: 2021-07-19
- Condition / research focus
- Diabetes Mellitus, Type 2
- Sponsor
- Eli Lilly and Company
- Countries with listed sites
- Germany
- Registry dates and results
- Start: 2019-10-27. Completion: 2021-07-08 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- LY3305677 (drug)
- Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Profil Institut für Stoffwechselforschung
Neuss, North Rhine-Westphalia, Germany
Site recruitment: Not reported